BioLineRx to Raise $6M through Direct Offering

Monday, 1 April 2024, 13:14
BioLineRx is set to raise $6M through a direct offering by selling 7.5M American depositary shares (ADS) and warrants at a combined price of $0.80 per ADS. This move aims to secure additional funds for the company's growth initiatives and strategic plans. Investors can participate in the offering to support BioLineRx's expansion in the biopharmaceutical industry.
LivaRava Finance Meta Image
BioLineRx to Raise $6M through Direct Offering

BioLineRx Plans $6M Fundraising through Direct Offering

BioLineRx intends to raise $6M by offering 7.5M American depositary shares and warrants at a combined purchase price of $0.80 per ADS.

Do you want to advertise here? Contact us

Related posts

Do you want to advertise here? Contact us
Do you want to advertise here? Contact us
Newsletter

We carefully select news from the world of finance and publish it for our users. We understand the importance of reliable and up-to-date information for people in the financial world. Do you want to receive news in a convenient format and always have it at hand — subscribe to our newsletter and make your analytical work more effective.

Subscribe